Cantor Fitzgerald Reiterates Neutral on Humana, Maintains $395 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James has reiterated a Neutral rating on Humana (NYSE:HUM) and maintained a price target of $395.
September 10, 2024 | 3:35 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Cantor Fitzgerald has reiterated a Neutral rating for Humana, maintaining a price target of $395. This suggests that the analyst expects the stock to perform in line with the market.
The reiteration of a Neutral rating and maintenance of the price target indicates that the analyst does not foresee significant short-term changes in Humana's stock price. This suggests stability in the company's current market position.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100